| Description | ELF4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ELF4 siRNA-1: 5 nmol (HPLC) ELF4 siRNA-2: 5 nmol (HPLC) ELF4 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 ELF4 Human Pre-designed siRNA Set A contains three designed siRNAs for ELF4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components ELF4 siRNA-1: 5 nmol (HPLC) ELF4 siRNA-2: 5 nmol (HPLC) ELF4 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Inquire | Heme Oxygenase-1-IN-1 (Compound 2) is a heme oxygenase 1 ( HO-1 ) inhibitor with an IC 50 of 0.25 µMIC50& Target:IC 50 : 0.25 µM (HO-1) | Purity>95% SDS-PAGE.FunctionProbable cell adhesion protein | Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor ( IC 50 s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a Tankyrase-IN-2 (compound 5k) is a potent, selective, and orally active tankyrase inhibitor ( IC 50 s of 10, 7, and 710 nM for TNKS1, TNKS2 as well as PARP1, respectively). Tankyrase-IN-2 has favorable physicochemical profile and pharmacokinetic properties modulating Wnt pathway activity in a colorectal xenograft modelIn VitroTankyrase-IN-2 (1-10000 nM; 24 hours) leads to a dose-dependent increase of tankyrase protein abundance with an EC 50 of 320 nM in DLD1 cells. This is in the same potency range as the value for axin2 increase (EC 50 =319 nM). MCE has not independently confirmed the accuracy of these methods. They are for reference only.IC50& Target:IC50: 10 nM (TNKS1), 7 nM (TNKS2), 710 nM (PARP1)... Read More |